Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
5.06
-0.66 (-11.54%)
At close: Feb 21, 2025, 4:00 PM
5.08
+0.02 (0.40%)
After-hours: Feb 21, 2025, 7:59 PM EST
Ardelyx Revenue
In the year 2024, Ardelyx had annual revenue of $333.62M with 168.06% growth. Ardelyx had revenue of $116.13M in the quarter ending December 31, 2024, with 237.95% growth.
Revenue (ttm)
$333.62M
Revenue Growth
+168.06%
P/S Ratio
3.57
Revenue / Employee
$1,249,494
Employees
267
Market Cap
1.20B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 333.62M | 209.16M | 168.06% |
Dec 31, 2023 | 124.46M | 72.30M | 138.61% |
Dec 31, 2022 | 52.16M | 42.06M | 416.57% |
Dec 31, 2021 | 10.10M | 2.53M | 33.36% |
Dec 31, 2020 | 7.57M | 2.29M | 43.36% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ARDX News
- 18 hours ago - 3 Biotech/Healthcare Names Under $10 I Am Buying Now - Seeking Alpha
- 1 day ago - Ardelyx, Inc. (ARDX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 days ago - Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 22 days ago - Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025 - GlobeNewsWire
- 5 weeks ago - Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities - GlobeNewsWire
- 6 weeks ago - Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Ardelyx Lost The Lawsuit, But The Kidney PATIENT Act Will Save It - Seeking Alpha